glutathione and antipsychotic Serum in Patients with Schizophrenia in Dynamics of Therapy | Bulletin of Experimental Biology Medicine Glutathione: a novel treatment target
Glutathione: a novel treatment target in psychiatry: Trends in Pharmacological Sciences The prefrontal cortex as a target for atypical antipsychotics in schizophrenia, lessons of neurodevelopmental animal models ScienceDirect Gut microbiota derived ergothioneine alleviates antipsychotic induced synaptic and cognitive impairments ScienceDirect Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first episode psychosis: A Longitudinal, Randomised, Triple blind, Placebo controlled MRI Study Neuropsychopharmacology
Pay in 4 interest-free payments of $6.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20



